European Porphyria Initiative (EPI): A platform to develop a common approach to the management of porphyrias and to promote research in the field

Physiological Research

Volumn 55, Issue SUPPL. 2, 2006, Pages

  Deybach, J Ch ^a   Badminton, M ^b   Puy, H ^a   Sandberg, S ^c   Frank, J ^d   Harper, P ^e   Martasek, P ^f   Minder, E ^g   Parker, S ^h   Thunell, S ^e   Elder, G ^b  

^a HÔPITAL LOUIS MOURIER   (France)

^b UNIVERSITY HOSPITAL OF WALES   (United Kingdom)

^c RWTH AACHEN UNIVERSITY   (Germany)

^d KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^e CHARLES UNIVERSITY   (Czech Republic)

^f Stadtspital Triemli ^*  (Switzerland)

^g Orphan Europe   (France)

^h HAUKELAND UNIVERSITY HOSPITAL   (Norway)

Author keywords

European porphyria initiative; Haem; Porphyrias

Indexed keywords

ADVISORY COMMITTEE; ARTICLE; ECONOMICS; EUROPE; HUMAN; INTERNET; MEDICAL RESEARCH; ORGANIZATION AND MANAGEMENT; PORPHYRIA; PRACTICE GUIDELINE;

ADVISORY COMMITTEES; BIOMEDICAL RESEARCH; EUROPE; HUMANS; INTERNET; PORPHYRIAS; PRACTICE GUIDELINES;

EID: 33847138626     PISSN: 08628408     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (15)

1. ANDERSON KE, SASSA S, BISHOP DF, DESNICK RJ: Disorders of heme biosynthesis; X-linked sideroblastic anemia and the porphyrias. The metabolic & molecular bases of inherited disease; eighth edition, Vol II, chapter 124, 2991.
2. DEYBACH JC, PUY H: The Porphyrias. Conn's Current Therapy, 56th ed., section 6, chapter 122, RAKEL RE, BOPE ET (eds), WB Saunders Company Elsevier USA, 2004, pp 494-500.
3. ENGELHARDT K, TRINKA E, FRANZ G, UNTERBERGER I, SPIEGEL M, BEER R, PFAUSLER B, KAMPFL A, SCHMUTZHARD E: Refractory status epilepticus due to acute hepatic porphyria in a pregnant woman: induced abortion as the sole therapeutic option? Eur J Neurol 11: 693-697, 2004.
4. ELDER G, HIFT R: Treatment of acute porphyria. Hospital Medicine, July 2001, Vol 62, No 7.
5. JAMES, MFM, HIFT RJ: Porphyrias. Br J Anaesth 85: 143-153, 2000.
6. MCNEILL, MJ, BENNET A: Use of regional anaesthesia in a patient with acute porphyria. Br J Anaesth 64: 371-373, 1990.
7. BROWN, WELBURY: The management of porphyria in dental practice. Br Dent J 193: 145-146, 2002.
8. HAHN M, GILDEMEISTER OS, KRAUSS GL, PEPE JA, LAMBRECHT RW, DONOHUE S, BONKOVSKY HL: Effects of new anticonvulsant medications on porphyrin synthesis in cultured liver cells: potential implications for patients with acute porphyria. Neurology 49: 97-106, 1997.
9. ZADRA M, GRANDI R, ERLI LC, MIRABILE D, BRAMBILLA A: Treatment of seizures in acute intermittent porphyria: safety and efficacy of gabapentin. Seizure 7: 415-416, 1998.
10. KRIJT J, KRIJTOVA H, SANITRAK J: Effect of tiagabine and topiramate on porphyrin metabolism in an in vivo model of porphyria. Pharmacol Toxicol 89: 15-22, 2001.
11. MCGUIRE GM, MACPHEE GJ, THOMPSON GG, MOORE MR, BRODIE MJ: Effects of sodium valproate on haem biosynthesis in man: implications for seizure management in the porphyric patient. Eur J Clin Invest 18: 29-32, 1988.
12. MCGUIRE GM, MACPHEE GJ, THOMPSON GG, PARK BK, MOORE MR, BRODIE MJ: The effects of chronic carbamazepine treatment of haem biosynthesis in man and rat. Eur J Clin Pharmacol 35: 241-247, 1988.
13. REYNOLDS NC Jr, MISKA RM. Safety of anticonvulsants in hepatic porphyrias. Neurology 31: 480-484, 1981.
14. LARSON AW, WASSERSTROM WR, FELSHER BF, CHIH JC: Posttraumatic epilepsy and acute intermittent porphyria: effects of phenytoin, carbamazepine, and clonazepam. Neurology 28: 824-828, 1978.
15. LAMBRECHT RW, GILDEMEISTER OS, PEPE JA, TORTORELLI KD, WILLIAMS A, BONKOVSKY HL: Effects of antidepressants and benzodiazepine-type anxiolytic agents on hepatic porphyrin accumulation in primary cultures of chick embryo liver cells. J Pharmacol Exp Ther 291: 1150-1155, 1999.